Hasil Pencarian - "Sloan Kettering"

Perbaiki Hasil
  1. 1
  2. 2
  3. 3

    Memorial Sloan-Kettering Cancer Center: Two Decades of Experience with Ductal Carcinoma In Situ of the Breast oleh Daniel Xavier Choi, Kimberly J. Van Zee

    Diterbitkan 2012-01-01
    "…Researchers at Memorial Sloan-Kettering Cancer Center have investigated many aspects of their experience with ductal carcinoma in situ of the breast over the past 20 years. …"
    Dapatkan teks lengkap
    Artikel
  4. 4

    Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience oleh Gerald A. Soff, Jodi Mones, Cy Wilkins, Sean Devlin, Eva Haegler‐Laube, Jonathan Wills, Debra M. Sarasohn, Krishna Juluru, Michael Singer, Yimei Miao, Jeanette Batista, Simon Mantha

    Diterbitkan 2019-07-01
    "…Objectives The Memorial Sloan Kettering Cancer Center Clinical Pathway has served as the institutional guideline for the use of rivaroxaban to treat CAT since 2014. …"
    Dapatkan teks lengkap
    Artikel
  5. 5

    Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience oleh Maria Rubinstein, Darragh Halpenny, Vicky Makker, Rachel N. Grisham, Carol Aghajanian, Karen Cadoo

    Diterbitkan 2019-05-01
    "…We performed a retrospective analysis of patients who were retreated with PC chemotherapy for recurrent EC at Memorial Sloan Kettering Cancer Center between January 2000 and December 2014. …"
    Dapatkan teks lengkap
    Artikel
  6. 6
  7. 7

    Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms oleh Michael Tzeng, Emily Vertosick, Spyridon P. Basourakos, James A. Eastham, Behfar Ehdaie, Peter T. Scardino, Andrew J. Vickers, Jim C. Hu

    Diterbitkan 2021-08-01
    "…We investigated whether the inclusion of PSA density or prostate volume in the Memorial Sloan Kettering Cancer Center nomograms improves the prediction of biochemical recurrence (BCR) after radical prostatectomy (RP). …"
    Dapatkan teks lengkap
    Artikel
  8. 8

    Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model oleh Christodoulou Christos, Skolarikos Andreas, Xanthakis Ioannis, Stravodimos Kostas, Anastasiou Ioannis, Kontovinis Loukas, Andreadis Charalambos, Papazisis Kostas, Timotheadou Eleni, Malettou Lia, Lainakis George, Lampaki Sofia, Karadimou Alexandra, Bamias Aristotelis, Syrigos Kostas, Papandreou Christos, Razi Evangelia, Dafni Urania, Fountzilas George, Dimopoulos Meletios A

    Diterbitkan 2010-02-01
    "…We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the established Memorial Sloan Kettering Cancer Center (MSKCC) model.</p> <p>Methods</p> <p>This is a retrospective analysis of patients treated in six Greek Oncology Units of HECOG. …"
    Dapatkan teks lengkap
    Artikel
  9. 9

    Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population. oleh Donglai Chen, Beihai Jiang, Jiadi Xing, Maoxing Liu, Ming Cui, Yiqiang Liu, Zaozao Wang, Lei Chen, Hong Yang, Chenghai Zhang, Zhendan Yao, Nan Zhang, Jiafu Ji, Hong Qu, Xiangqian Su

    Diterbitkan 2013-01-01
    "…Since the clinicopathologic characteristics of gastric cancer vary widely between China and western countries, this study is to evaluate a nomogram from Memorial Sloan-Kettering Cancer Center (MSKCC) for predicting the probability of DSS in patients with gastric cancer from a Chinese cohort. …"
    Dapatkan teks lengkap
    Artikel
  10. 10

    USEFULNESS AND PREDICTIVE POWER OF MEMORIAL SLOAN-KETTERING CANCER CENTER NOMOGRAM IN NON-SENTINEL LYMPH NODE METASTASES OUT OF SENTINEL LYMPH NODE METASTASED BREAST CANCER PATIENTS oleh Ali Aktekin, Günay Gürleyik, Pembegül Güneş, Seyfi Emir, Abdullah Sağlam

    Diterbitkan 2009-10-01
    "…To defi ne the predicting power and availability of the nomogram, this has been developed in Memorial Sloan-Kettering Cancer Center by Zee et al, in non-SLN involved patients among breast cancer patients with SLN involvement.Patients and Methods: The variables used in Memorial Sloan-Kettering Cancer Center nomogram (pathologic size, type, nuclear grade, lymphovascular invasion, multifocality, estrogen receptor positivity of the tumor, defi ning methods of SLN metastases, positive and negative SLN numbers) are evaluated. …"
    Dapatkan teks lengkap
    Artikel
  11. 11
  12. 12
  13. 13

    A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay oleh Rachel Y. Lei, MA, Dennis L. Carter, MD, Andrew G. Antell, MD, Molly A. Nowels, MA, MS, Shannon P. Tole, BA, John P. Bennett, MPH, Michelle Turner, MS, Frederick L. Baehner, MD, Charles E. Leonard, MD

    Diterbitkan 2021-03-01
    "…Purpose: To compare ipsilateral breast event (IBE) risks in patients with ductal carcinoma in situ of the breast (DCIS) post-lumpectomy, as estimated by breast radiation oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center (MSKCC) DCIS nomogram, and the 12-gene Oncotype DX DCIS score assay. …"
    Dapatkan teks lengkap
    Artikel
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20